Antony A. Riley

Antony A. Riley is a declared insider of Forte Biosciences, Inc. (finance chief), with filings sourced from SEC (Form 4). In total, 20 filings cover trades dated from 7 September 2021 to 27 August 2026.

Market trades split into 2 purchases (€335k) and 1 sale (€77k). Netting one side against the other leaves €258k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants and 13 option exercises. Since January 2026: 1 purchase and no sales on the market.

The newest entry dates from 27 August 2026: a transaction, in Forte Biosciences, Inc. The last purchase on record was published on 2 January 2026, which is 289 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.